The Independent Voice of
European Private Equity

Advanced Search

Archimed’s Diesse develops blood test for Covid-19 virus

Samantha Birchall 23 March 2020

  • Diesse is one of five ArchiMed portfolio companies actively fighting COVID-19. 
  • The blood test is one of the only methods known to accurately track Covid-19 antibodies, which will play a...

Related Articles